Common Names
Geographic Range: Indian subcontinent (primary), Southeast Asia; cultivated pantropically
Known Contraindications
1
Compounds
2
Traditions
2
Treatments
3
Conditions
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1OCYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | moderate inhibitor |
| CYP2B6 | weak inhibitor |
| CYP2C9 | moderate inhibitor |
| CYP2D6 | weak inhibitor |
| CYP3A4 | moderate inhibitor |
| CYP2C19 | weak inhibitor |
| UGT_note | Primary metabolism via UGT1A1, UGT1A3 (glucuronidation), not CYP — but CYP inhibition still clinically relevant |
| clinical_note | Inhibits CYP3A4, CYP2C9, CYP1A2 — caution with warfarin, theophylline, narrow therapeutic index drugs |